Home › Medicine › Reliance Life Sciences Private Limited
Reliance Life Sciences Private Limited Check your batch
Check the batch codes below. If yours matches, return it for a refund rather than take it.
Class II
- May cause temporary or medically reversible harm. Serious consequences are unlikely.
- Refunds don't require a receipt, and you don't need proof of purchase.
- FDA status: Ongoing.
What was recalled
Source: FDA · synced 29 Jul 2026 13:14 Check your batch Filed 2026-07-15
Lack of Sterility Assurance
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Check these codes: Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028
Ad slot · height reserved before load
Watch Reliance Life Sciences Private Limited for new recalls
One email per recall. Nothing else, ever.